The objective of this paper is to provide an overview of advanced information-guided surgical management technology of intracranial gliomas implemented in Japan, represented by the Intelligent Operating Theater at the Tokyo Women's Medical University, established in 2000, where more than 1000 patients with various intracranial pathology have received neurosurgical treatment with application of the intraoperative MRI, updated neuronavigation, and advanced neurophysiological and histopathological monitoring. Additionally, a dedicated computer-based system for accumulating, storing, integrating, and analyzing various surgical data was developed, which provided an opportunity for adequate risk management and prediction of the surgical results. Application of these modalities and tools led to significant improvements in both surgical outcome and long-term patients' prognosis. Further technological developments, such as new therapeutic robot, dedicated laser, and high intensity focused ultrasound are currently under investigation. The final goal is to integrate all these devices and systems into comprehensive neurosurgical framework.
INTRODUCTION
To date the clinical decision making is significantly influenced by the personal intuition and previous experience of the doctor. Experienced neurosurgeon is able to simulate the whole upcoming surgery in mind and to perform it on patient precisely and efficiently.
Figure 1.
General framework of the information-guided and precision-guided brain surgery in Tokyo Women's Medical University. iMRI: intraoperative MRI. Pre-op.: preoperative. Intra-op.: intraoperative.
the diagnostic and management data of the particular patient (advanced surgeon's "eye"), special computer-aided systems for comprehensive analyses of these data and simulation of the treatment course (advanced surgeon's "brain"), and dedicated instrumentarium for greater efficacy of the surgical manipulations (advanced surgeon's "hand"). The present report summarizes the experience with advanced information-guided surgical management of the intracranial gliomas gained in Tokyo Women's Medical University (TWMU) from 2000 to 2011. It describes the strategy for advanced intraoperative visualization of the neoplasm and identification of its borders with the adjacent brain tissue, highlights currently available computer-aided systems for facilitating and support of the surgical decision-making, shows the outcome of brain tumor surgery in the Intelligent Operating Theater (IOT), underlines clinical rationale for aggressive resection of gliomas, and presents some dedicated devices which have a significant potential to improve efficacy of the neurosurgical procedures in the nearest future while still in the preclinical stage of testing. It should be underlined that detailed analysis of the clinical results is beyond the scope of this study, which is rather directed on characterization of the advanced intraoperative technologies currently available for surgical management of glioma and presentation of our treatment concept.
METHODS
From March 2000 to August 2011, more than 1000 neurosurgical interventions for various intracranial pathology were performed in the IOT of TWMU. Approximately three quarters of these procedures, including 242 awake craniotomies, were directed on resection of intracranial gliomas. The present analysis of the advanced intraoperative technology and general surgical outcome did not require any special permission or approval by the committee for protection of human subjects in research.
Advanced Intraoperative Technology of the IOT of TWMU 2.1.1. Intraoperative MRI
The organization of the IOT of TWMU is illustrated in Figure 2 . It is equipped with a low-field-strength (0.3 Tesla) open intraoperative magnetic resonance imaging (iMRI) scanner (AIRIS II TM ; Hitachi Medical Corporation, Tokyo, Japan) in a hamburger-like shape, with a 43 cm gantry gap and a disc-shaped permanent magnet producing vertical magnetic field with resonance frequency of 12.7 MHz. This scanner does not require a cooling system, thus significantly reducing its operating cost by approximately 10.000 Japanese yen (around US$100) per month. The low magnetic field strength creates a narrow 5-gauss zone, extending 2 meters from both sides, 2.2 meters in front, 1.8 meters backwards, and 2.5 meters upwards, which allows for the surgeon to use some conventional surgical instruments (e.g., high-speed drill) in the working space outside such area. Nevertheless, all surgical devices used within the 5-gauss line, such as operating table (MOT2000-MRI; Mizuho Ltd., Tokyo, Japan) and operating microscope (MRI-30; Mitaka Co., Tokyo, Japan) are constructed from non-ferromagnetic material to prevent accidents and avoid image artifacts. The specially developed radiofrequency receiver coil integrated with the Sugita headholder (Head-holder coil; Mizuho Ltd., Tokyo, Japan) significantly improves the quality of the intraoperative images [1-5].
Intraoperative Neuronavigation
Simultaneous with installation of iMRI in IOT of TWMU, a special system for neuronavigation based on the intraoperative neuroimaging was developed in 2000 [1, 2] . Its main advantage is avoidance of the adverse effects caused by brain shift and deformation, allowing precise identification of the tumor position and its interrelationships with surrounding brain structures. To facilitate tumor removal and detection of the neoplastic remnants we use previously developed navigator for photon radiosurgery system (PRS navigator; Toshiba Medical Co. Ltd., Tokyo, Japan), which allows fast and easy updating of the information obtained with iMRI. The mislocalization error of the device is 0.8 mm in average, 1.5 mm at maximum, and 0.5 mm at minimum, and typically does not exceed 1 mm [1, 2] . The system permits co-registration, fusion and three-dimensional reconstruction of various images, and 554
Information-Guided Surgery of Intracranial Gliomas provides easy-to-understand information. The different areas of the perilesional brain can be color-coded according to the safety of manipulations and probable risk of complications. Additionally, the device may be integrated with special sound alarm automatically activated if surgical instruments are coming in close proximity to the high-risk area.
Intraoperative Neurophysiological Monitoring and Brain Mapping with Awake Craniotomy
Comprehensive intraoperative neurophysiological monitoring is routinely implemented during surgical procedures in the IOT of TWMU [5, 6] . The level of anesthesia, which may interfere with results of such examinations, is constantly monitored with bispectral index (BIS) monitor. Somatosensory evoked potentials (SEP) are recorded with stimulation of the median nerve. The values of the latencies and amplitudes obtained after craniotomy just before the dural incision are considered as an individual baseline. The central sulcus is localized based on the polarity inversion of the N20 component of SEP. Motor evoked potentials (MEP) are monitored using transcranial electrodes and measurement of the electromyograms at the thenar, quadriceps femoris, anterior tibial, and gastrocnemius muscles on both sides. Direct cortical mapping of the primary motor area is also performed.
Neurochemical Navigation with 5-ALA and Intraoperative Histopathological Diagnosis
During surgery for intracranial gliomas neurochemical navigation with 5-aminolevulinic acid (5-ALA) and intraoperative microscopic investigation of the pathological material on the frozen sections are routinely performed for identification of the remnants of the neoplasm and detailed histopathological characterization of the resected tissue [7] .
Intraoperative Examination Monitor for Awake Surgery (IEMAS)
In 2004, a dedicated device called Intraoperative Examination Monitoring system for Awake Surgery (IEMAS) was developed by our group and incorporated into clinical practice during awake craniotomy for lesions located in or in the nearest vicinity to eloquent cortical areas [2, 5, 8] . As shown in Figure 3 , this device integrates seven channels from video sources of various anatomical and functional parameters, including the view of the patient's face, examination task, level of sedation (BIS monitor), view of the surgical field, and display of the neuronavigation system. Surgeons can observe various intraoperative data simultaneously on one display and record it in the integrated format. All members of the surgical team can visualize and analyze the information practically without interruption of the surgical manipulations.
Surgical Information Strategy Desk
For appropriate analysis of various surgical data a special computer-assisted system, "Surgical Information Strategy Desk", was designed and installed in the surgical office [2, 5] .
All pre-and intra-operative information can be viewed through eight LCD displays. This system is located in a dedicated center for researchers specializing in medicine, biotechnology, pharmacology and engineering, as well as the basic sciences of chemistry and physics.
Strategy for Management of Intracranial Glioma 2.2.1. Surgical Concept and Objectives
The concept of the information-guided surgical management of gliomas based on the integration of various intraoperative anatomical, functional, and histopathological data is depicted in Figure 4 . The resection rate is mainly determined by 3 interrelated factors: tumor size, histopathological grade, and functional grade [1, 5, 9] . The goal of surgery is defined as maximal possible removal of the neoplasm, which can be radiologically total or subtotal removal, assessed by the size of the residual lesion within the functioning eloquent brain structures identified with neurophysiological monitoring and/or brain mapping. In general, the optimal result corresponds to elimination of the whole area of hyperintense signal detected on preoperative T2-weighted or FLAIR images. It can be often achieved in cases of low-grade neoplasms, but rarely attained in high-grade lesions surrounded by prominent Information-Guided Surgery of Intracranial Gliomas peritumoral edema. In the latter case, the surgery is usually aimed at maximal removal of the contrast-enhanced area. Finally, in the rare occasions of extensive tumors affecting functioning eloquent brain structures the surgery is aimed at removal of the most metabolically active part of the neoplasm detected by 11 C-methionine uptake on PET.
Guidance of Tumor Resection
The initial iMRI investigation with subsequent installation of data in the neuronavigation system is performed after craniotomy and completion of the approach to the tumor. After removal of the neoplasm, the investigation is repeated for assessment of the completeness of resection, identification of the residual lesion or possible adverse effects such as hemorrhage. If residual glioma is identified and considered suitable for additional resection, the newly obtained iMRI data are installed in the neuronavigation device and further removal of the neoplasm is performed using this updated information. After completion of such additional resection iMRI is repeated once again. However, such anatomical data are used for removal of the bulk of the tumor only, whereas resection of the residual neoplasm is based not only on the anatomical images, but on the results of neurochemical navigation with 5-ALA and histopathological investigation of the walls of the surgical cavity [9] . It should be noted that neither anatomical data obtained with iMRI nor histopathological information on the presence of residual neoplasm is sufficient for Main principle of the information-guided surgery for glioma. To maximize resection rate and minimize complication rate, anatomical, functional, histological, and metabolic data, etc. are needed. Anatomical data are integrated with functional and histological data by neuronavigation (section 2.1.2); however, functional data have definite priority in surgical decision-making. iMRI: intraoperative MRI. MEP: motor evoked potentials. SEP: somatosensory evoked potentials. Histological information histology on frozen sections guidance of the tumor resection, especially if the lesion is located near or within functionally-important cerebral structures. In all circumstances, the first priority in surgical decision-making is given to functional information provided by intraoperative brain mapping and comprehensive neurophysiological monitoring.
Evaluation of Resection Rate
Resection rate of intracranial gliomas is evaluated by postoperative 1.5 Tesla MRI. In cases of contrast-enhanced tumors the investigation is usually performed within 48 to 72 hours after surgery, while after removal of non-enhancing low-grade neoplasms it is frequently delayed up to 5 to 7 days for the resolution of possible postoperative brain edema which may result in overestimation of the residual lesion [10] . If elimination of 95% or more of the mass in terms of signal hyperintensity on T2-weighted images in cases of low-grade neoplasms, or contrast-enhanced area on postgadolinium T1weighted images in cases of high-grade ones is confirmed, the resection is considered total. Such cut-off level corresponds to the grading of resection of gliomas adopted by The Committee of Brain Tumor Registry of Japan [11] . Volumetric methods for postoperative evaluation of brain tumors are not employed routinely, since they are not required by the Response Assessment in Neuro-Oncology (RANO) working group and are still considered a field of major research [12, 13] .
Postoperative Management of Brain Tumors
After the surgery for intracranial gliomas, all patients receive regular clinical and radiological examinations by the treating neurosurgeons in the outpatient clinic. Our strategy for postoperative management of such tumors is presented in Table 1 .
558
Information-Guided Surgery of Intracranial Gliomas The diagnosis of tumor re-growth or recurrence is based on the joint opinion of the neurosurgeon and neuroradiologist, and is defined as 25% or more increase of the volume of the previously existent lesion or appearance of the new lesion on postcontrast T 1 -weighted MR images. At the time of tumor progression the vast majority of patients receive salvage treatment, which usually include re-resection of the neoplasm, stereotactic radiosurgery, chemotherapy, vaccine therapy, or their various combinations.
Collection and Assessment of Clinical Information
All pre-operative, intraoperative, and follow-up clinical data are collected by dedicated staff members not involved in the direct treatment of patients. This information is preserved in constantly maintained computer database and available for immediate use upon the request of attending neurosurgeons.
RESULTS
The length of brain tumor surgery in IOT of TWMU usually varied from 8 to 12 hours depending on the size and location of the neoplasm, and the number of iMRI investigations.
Radiologically total removal of glioma was achieved in 46% of cases. Subtotal removal was performed in 53% of patients, leaving the remnants of the neoplasm within the functioning eloquent brain structures identified by intraoperative brain mapping and comprehensive neurophysiological monitoring. The mean resection rate was 92% for all histopathological grades, with the medians of 91%, 93%, and 92% for WHO grade II, III, and IV neoplasms, respectively. The median residual tumor volume was 0.17 cc. In general, the residual tumor volume was greater in neoplasms of higher histopathological and functional grade, but such trend did not reach statistical significance. Unexpected residual tumor was never disclosed by postoperative MRI (1.5 Tesla) which has a much higher magnetic field strength compared to iMRI (0.3 Tesla).
Improvements of pre-existing signs and symptoms were noted in 13% of the patients. Permanent neurological deterioration after surgery occurred in 12% of cases, but it reduced to 9% after intentional decrease of the resection rate in our latest cohort of patients with WHO grade II and III gliomas. Wound infection after removal of the tumor was observed in 2% of cases. Postoperative hemorrhage never occurred in any case.
In patients with available long-term follow-up the prognosis was significantly worse for cases of WHO grade IV gliomas, but did not reach statistically significant differences between WHO grades II and III tumors [14] , as illustrated in Figure 5 . Among individuals with WHO grades II, III, and IV gliomas, who were followed for more than 2 years after surgery, the corresponding actuarial 5-year survival rates were 87%, 69%, and 19%, respectively. In patients with low-grade glioma the extent of tumor resection was significantly associated with prolonged overall survival, progression-free survival, and malignant-progression-free survival.
DISCUSSION
The well-known benefits of resective surgery in cases of glioma include relief of compression of the tumor bulk on the surrounding brain (important for neurological improvement) and establishment of the precise histopathological diagnosis, which determines choice of the adjuvant therapy, optimal follow-up, and predicts prognosis. Additionally, reduction of the mass volume can render postoperative radiochemotherapy more effective [15] .
Extensive removal of the tumor may positively influence patients' survival [16] . Stummer et al. [17] adjusted biases of age and eloquent area location in the dataset of a randomized study on use of neurochemical navigation with 5-ALA during resection of glioblastoma multiforme (GBM), and found that median overall survival time after complete removal of the contrast-enhanced lesion was significantly longer compared to incomplete resection (17 months vs. 12 months). Further, in the report on a randomized trial of combined chemotherapy for anaplastic gliomas performed by the European Organization for Research and Treatment of Cancer (EORTC), the overall survival was better after complete tumor removal compared to partial removal or biopsy [18] . It was demonstrated that 98% or more resection of GBM is associated with significant improvement of the long-term outcome [19] , and the same trend was recently revealed even at 78% resection rate [20] . Similar results were reported by the Committee of Brain Tumor Registry of Japan [11] that analysis 560
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Figure 5.
Overall survival rate of patients with gliomas of different histopathological grades. Based on the Cox proportional hazard model, there is no significant difference between neoplasms of grades II and III (p = 0.1742), but there is a significant difference between grades III and IV (p < 0.0001). Source: Shinohara et al. [14] , adopted with permission. Months Survival rate of 9,234 cases of malignant gliomas showed that more than 95% of tumor removal is associated with survival advantage, while such resection rate was attained in one third of cases only. Of special importance is the fact that aggressive resection of the neoplasm may provide survival advantage even in patients with prognostically unfavorable RPA classes IV and V [21] . As reported above in the RESULTS section, the 5-year survival rates of our patients were 87%, 69%, and 19% for WHO grades II, III, and IV gliomas, respectively, compared to 41% for all gliomas, 22% for high-grade ones, and 7% for glioblastomas in general neurosurgical practices, according to the Committee of Brain Tumor Registry of Japan [11] . It should be specifically emphasized that complete surgical resection is highly desirable, but not the ultimate goal of surgery for glioma; therefore it should not be performed if it may cause major permanent postoperative neurological morbidity or lead to significant decline of the quality of life.
Advanced Surgeon's "Eye"

Intraoperative MRI
The iMRI systems were first introduced to neurosurgery at the end of 1990's. Since then, such devices have been used for real-time imaging for surgical manipulations, for assessment of the extent of tumor resection, and evaluation of the intraoperative complications. While real-time guidance of the surgical manipulations with iMRI is theoretically presumed to be the most effective, such systems usually reduce the work space available and necessitate all surgical devices to be made of nonferromagnetic materials. In contrast, if iMRI scanning is performed at some temporary break points during surgical procedure, it can provide a higher degree of freedom for the surgeon and allow the use of standard (not MRI-compatible) neurosurgical instrumentarium [1, 2, 5, [22] [23] [24] . It should be noted that employment of any type of iMRI system increases the operation time, because MR imaging itself is a time-consuming process.
During the last decade there is a trend of employing iMRI scanners with high magnetic field strength of 1.5 and 3 Tesla [25] [26] [27] . Their advantages include high image quality, possibility to attain diffusion tensor and spectroscopic images, as well as short scanning time [25] . Increase of magnetic field strength, however, is associated with greater possibility of image distortion artifacts. The risk of the latter is 5 times greater in a 1.5 Tesla MR scanner compared to a 0.2 Tesla one [28] . Additionally, the maintenance cost of high-field-strength iMRI scanners is significantly higher.
The magnetic field strength of the iMRI installed in IOT of TWMU is only 0.3 Tesla; nevertheless, it is able to obtain not only volumetric MR images, but to perform MR angiography and functional investigations [2, 5, 22] by using a specially developed Head-holder coil. Integration of such coil with modified Komai stereotactic frame allows stereotactically guided surgical procedures under the control of iMRI [2] . The most important achievement is the ability to obtain intraoperative diffusion-weighted images (iDWI) which provide nearly real-time information on spatial interrelationships between the pyramidal tract, the lesion, and positions of the surgical instruments including the electrical stimulator for subcortical functional mapping [3, 4] . iDWI can effectively prevent inadvertent injury of the pyramidal tract and thus avoid postoperative deterioration of the motor function. The estimated positional accuracy of iDWI in our practice is within 5 mm, comparable to the conducting depth of the electrical stimulation for subcortical brain mapping [6] . It should be noted, however, that diffusion anisotropy of the white matter tracts may be reduced due to presence of the tumor or peritumoral edema, and possibly leading to poor visualization of the pyramidal tract on the affected side.
Recent prospective randomized trial of Senft et al. [29] demonstrated that iMRI has significant positive impact on the resection rate. In 96% of cases it allowed complete removal of the contrast-enhancing intracranial gliomas amenable for aggressive surgery, whereas in one third of patients use of intraoperative imaging directly led to extended tumor resection. The volume of the residual neoplasm after iMRI-guided surgery was significantly smaller than after conventional procedure, and fewer patients in the former group had progressive disease 6 months after intervention. Overall, the results were considered comparable to previously reported efficacy of the intraoperative neurochemical navigation with 5-ALA, although the two methods were not directly compared [29] . In our practice both techniques are constantly applied for optimal identification of the residual neoplasm and evaluation of its interrelationships with the functioning brain tissue.
Neurochemical Navigation with 5-ALA
Neurochemical navigation with 5-ALA during resection of gliomas is based on the effect of its accumulation in the tumor cells and areas with impaired blood-brain barrier (BBB) and further conversion into protoporphyrin IX whose fluorescence is visible under ultraviolet light. This method can be effectively used for identification of the neoplastic tissue and its differentiation from the brain itself, which may be particularly important at the periphery of the neoplasm. Large prospective multicenter randomized phase III trial clearly demonstrated that compared to conventional microsurgery use of neurochemical navigation with 5-ALA results in significantly greater proportion of complete resections of glioblastoma (defined as absence of the contrast-enhancing area on postoperative MRI), smaller volume of the residual tumor, and better progressionfree survival 6 months after intervention [30] .
It should be noted, however, that erroneous results of neurochemical navigation with 5-ALA are possible. False negative results may occur in low-grade gliomas due to relative preservation of the BBB or the presence of the adherent blood on the tissue surface since erythrocytes can absorb ultraviolet light, which in such case does not reach protoporphyrin IX in the pathological tissue [7] . Contrarily, false positive fluorescence may be observed in the areas with high vascularization, reactive astrocytosis, or BBB impairment in the absence of the neoplastic elements [7] . Regular intraoperative histopathological investigation of the resected tissue on the frozen sections effectively complement neurochemical navigation and may be efficiently used for guidance of the tumor resection, identification of the neoplastic remnants, and confirmation of completeness of the lesion removal.
Advanced Surgeon's "Brain" 4.2.1. Importance of the Neurophysiological Information during Glioma Resection
It should be clear that anatomical and histopathological data alone, even if obtained with iMRI, neurochemical navigation with 5-ALA, and regular intraoperative histopathological investigations of the walls of the surgical cavity, are not sufficient for guidance of the glioma resection. Location of the eloquent brain structures has known individual variability and may be displaced during growth of the neoplasm, thus necessitating comprehensive neurophysiological monitoring and intraoperative cortical and subcortical brain mapping with or without awake craniotomy, and further integration of the neurophysiological, histopathological, and anatomical data within the updated neuronavigation system [6, [31] [32] [33] [34] . In all circumstances, the first priority in surgical decision-making should be given to functional information, especially in cases with critical location of the neoplasm [5, 9, 33, 34] .
Intraoperative Examination Monitor for Awake Surgery (IEMAS)
The effectiveness of the information-guided tumor resection is strongly dependent on the quality of the available information. Particularly, during surgery for cerebral glioma preservation of the cortical speech centers is of paramount importance for preventing postoperative aphasia. It enforces awake craniotomy with intraoperative brain mapping for localization of the functionally important structures [35] [36] [37] . Such technique requires synchronization of the cortical electrical stimulation and functional testing for precise identification of the targeted region. It usually takes two members of the surgical team to perform the task, with one conducting the examination test to the patient and the other applying cortical electrical stimulation. To simplify this process, we developed the dedicated IEMAS which integrates various types of related information on one screen. The device is currently in the process of commercialization and receiving governmental authorization. Its latest improvement incorporated wireless audio-visual transmitting technology with paired signal transmitters and receivers for transfer of video images and verbal information [8] .
Surgical Information Strategy Desk
A variety of data are involved in a brain tumor removal surgery. "Surgical Information Strategy Desk" was developed to integrate different information and facilitate surgical decision-making [2, 5] . It provides an opportunity for the senior surgeon to observe simultaneously preoperative high-resolution diagnostic images by high-field MR scanner, surgical planning through computer simulation, surgical procedures performed by junior colleagues, intraoperative MR images, real-time update neuronavigation data, neurophysiological monitoring, histopathological investigation, etc. Using these data, optimal solutions for the ever changing surgical scenario can be effectively reached and communicated with the surgical staff. Various types of information are transferred to the command center, and distributed among other specialists, such as pathologist and engineer, via closed intra-hospital network. This enables emergency consulting service even if the specialists are located far away from the operating room. When surgical staff requests consultation, they just have to access the network, where all surgical data are progressively collected and integrated via intra-hospital network from their offices. Theoretically, monitoring the surgical procedure by a senior surgeon from a distant site away from the operating theater may create problems in case of some troubles, and may even have medico-legal implications. However, we never had such negative experience therefore its risk should not be overestimated.
Various intraoperative data incorporated into "Surgical Information Strategy Desk" are used not only during surgical procedure, but stored on the hard disk for further analysis. Such information may be used later for evaluation of the surgical procedure and analysis of the outcome, for simulation and creation of the surgical plan for future cases, and for educational purposes in training junior neurosurgeons. Another direction of use of the intraoperative data, which is currently implemented in our laboratory, is surgical workflow analysis aiming at simplification and optimization of the surgical procedures.
Analysis of Staff Movements inside the Operating Theater
Currently we are trying to establish the links between events on the recorded video images of the surgical procedure or of the operating theater and details of surgery particularly the adverse and undesirable events [38] . We hypothesize that when accident occurs, the movements of the surgical staff should increase, which should be reflected on the video file's size. In the interframe video compression algorithm, the subtraction data between two continuous frames is the dominant factor for determination of the video file size. If the surgical staff members increase their movements, the subtraction data increase and consequently the file size increases. Therefore, such method can be effectively employed to measure the quantity of movements on the video. To achieve our objective, the recorded video image is separated into a series of one-minute files. The size of each file corresponds to the number of movements within a specific period of time. It is therefore easy to identify occurrences of accidents during the surgery. In addition to nuisances, this method can further identify different events happening in the operating room. It was found, that the size of the video file well correspond to the stage of the surgical procedure, such as skull drilling, microsurgical tumor removal, intraoperative MR scanning. At present we are applying this method for automatic recognition of the surgical stage. In the meantime, statistical analysis of the video recordings from multiple surgical procedures may establish the "normal" or "standard" amount of the surgical staff motions during each stage of procedure, which opens a way to indirect identification of the various intraoperative accidents.
Advanced Surgeon's "Hand"
Robotic Neurosurgery
Incorporation of robotic systems into neurosurgical practice can potentially increase the precision of surgical manipulations, and significantly reduce the risk of neurological deficits if surgery is performed in highly vulnerable brain areas. The robotic systems can perform automatic distinction between the tumor and surrounding tissue, and may provide an opportunity for highly selective management of the neoplasm with extremely high precision [39] . Other potential advantages of robotics include the opportunity to perform manipulations in extremely limited space, and the possibility of initial computer-aided modeling and simulation of the planned surgical action. The introduction of the robotic technologies into clinical medicine started in the 1990s with such system as da Vinci (Intuitive Surgical Inc., Sunnyvale, CA, U.S.A). In the meantime, we developed a special neurosurgical robotic system, designated as the Hyper Utility Mechatronic Assistant for Neurosurgery (HUMAN) or NeuRobot (commercialized by Hitachi Medical Corporation, Tokyo, Japan). For the first time in the world it was clinically implemented at Shinshu University (Matsumoto, Japan) in August 2002 and proved the possible practical utility, particularly for the third vetnriculostomy [40] . Currently, an advanced iMRI-compatible model of this device is undergoing experimental testing.
The next generation of neurosurgical robots features integration of advanced intraoperative neurovisualization and computer technology for comprehensive data assessment, and will be able to perform highly selective automatic removal of the neoplasm with preservation of adjacent normal tissue (precision-guided surgery). We have been developing a manipulator based on the integration of the chemical neuronavigation for localizing the neoplasm in the surgical field and micro-laser for its ablation as illustrated on Figure 6 . Specially designed camera incorporated in this b a c Figure 6 .
Neurosurgical robotic system for tumor ablation. The device is fixed on the head of the operative microscope (a), and includes a micro-laser and a specially designed camera (b) for automatic determination of the management area to allow extremely limited thermal action with better than 0.5 mm positioning accuracy (c).
device allows automatic determination of the management area. A mid-infrared continuous wave micro-laser with a wave length of 2.8 micrometers provides optimal absorption parameters of the brain tissue and extremely limited thermal action. The system has a better than 0.5 mm positioning accuracy. All surgical actions are planned and controlled by the neurosurgeon at a distant desk. It should be noted that this device has been developed not for removal of the whole bulk of the tumor, but for management of its residuals in the highly eloquent brain structures where high levels of preciseness and safety are needed. It is expected that such highly selective pin point neurosurgery will enable removal of the neoplasm while keeping functionally important brain structures intact. The clinical testing of the device is expected in the nearest future.
High Intensity Focused Ultrasound (HIFU)
Another development among next generation of the therapeutic systems for brain tumor management is the High Intensity Focused Ultrasound (HIFU) developed as a prototype for novel high-precision device for guiding surgical procedures (joint project of TWMU, Tohoku University and Hitachi Medical Corporation). Its performance parameters, targeting accuracy, and therapeutic efficacy are currently under evaluation in the Intelligent Animal Operating Theater in Tokyo Women's Medical University-Waseda University Joint Institution (TWIns) for Advanced Biomedical Sciences, where the device is incorporated with the ultrasound imaging and iMRI systems. A set of animal experiments have been conducted to achieve from 75% to 80% reduction of the tumor growth and establishment of the optimal technical parameters and safety regulations for further application of the device to clinical trials.
CONCLUSION
Information-guided surgery of intracranial gliomas based on intraoperative integration of various anatomical, neurophysiological, and histopathological data enables aggressive tumor resection with minimal risk of permanent postoperative neurological morbidity, and may result in significant prolongation of patients' survival. Continual progress in advanced visualization, comprehensive medical information management, and robotics bring forth a great potential to further increase the efficacy and safety of the surgical procedures. 
